|Bid||42.58 x 600|
|Ask||42.59 x 800|
|Day's Range||42.11 - 42.63|
|52 Week Range||34.35 - 42.66|
|PE Ratio (TTM)||19.77|
|Forward Dividend & Yield||0.99 (2.51%)|
|1y Target Est||N/A|
Phillips' (PHG) first-quarter 2018 results benefit from its Diagnosis & Treatment businesses on the back of growth in Ultrasound, Diagnostic Imaging and Image-Guided Therapy.
There are a number of reasons that attract investors towards large-cap companies such as Koninklijke Philips NV. (ENXTAM:PHIA), with a market cap of €30.13B. Risk-averse investors who are attracted toRead More...
On a per-share basis, the Amsterdam-based company said it had net income of 16 cents. Earnings, adjusted for one-time gains and costs, were 20 cents per share. The medical imaging equipment maker posted ...
Philips (PHG.AS) is worried about rising trade tensions between the United States and China, said the Dutch health-technology company that is banking on continuing Chinese demand for its high-end medical equipment. Strong demand from Chinese hospitals for its ultrasound machines, medical scanners and other equipment helped Philips' first-quarter results beat analyst expectations on Monday, but the simmering trade dispute between the United States and China could threaten future earnings. "So far the effects are modest, but we are worried about the trade tensions," Chief Executive Frans van Houten told Reuters in a telephone interview.
Philips is worried about rising trade tensions between the United States and China, said the Dutch health-technology company that is banking on continuing Chinese demand for its high-end medical equipment. Strong demand from Chinese hospitals for its ultrasound machines, medical scanners and other equipment helped Philips' first-quarter results beat analyst expectations on Monday, but the simmering trade dispute between the United States and China could threaten future earnings.
AMSTERDAM (Reuters) - Dutch health technology company Philips (PHG.AS) on Monday said rising trade tensions between the United States and China are having a negative effect on its results, as they drive ...
Dutch health technology company Philips' first-quarter results beat expectations on Monday, as customers in China and the United States increased their demand for its high-end hospital equipment. Core profit in the first three months of the year rose 15 percent to 344 million euros ($422.1 million), Philips said, on a comparable sales growth of 5 percent and a 10 percent increase in new orders. "While there is more work to be done, 2018 started well," Chief Executive Frans van Houten said in a statement, reaffirming the company's target of a 4-6 percent sales growth for the year.
Royal Philips NV Chief Executive Officer Frans van Houten said the Dutch manufacturer of medical equipment remains on the hunt for companies to buy as it hones focus on the health-care sector. “We are interested to do bolt-on acquisitions,” he said in an interview on Monday with Bloomberg TV after publishing quarterly earnings. The company based in Amsterdam reported 10 percent growth in comparable order intake, reflecting a series of multi year contracts to provide imaging services to hospitals including in the U.K. and Canada.
Dutch health technology company Philips said on Monday its first quarter core profit rose 15 percent to 344 million euros , on increased demand from customers in China and the United States for its high-end ...
The oft-criticized name, merging the words “health” and “engineers,” actually belongs to a unit of German industrial conglomerate Siemens (ticker:ticker::SIE.Germany) that had a successful trading debut last month. While shares in Siemens Healthineers (SHL.Germany) have danced higher so far, investors might not want to bet that big gains will continue. Analysts say Royal Philips (PHIA.Netherlands) looks like the best competitor to compare Healthineers against.
On March 2, 2018, Hologic (HOLX) announced a global partnership with Royal Philips (PHG) to provide an integrated health solution for women comprised of diagnostic imaging modalities and advanced informatics along with screening, diagnosis, and treatment services. According to the agreement, some of the selected products from Hologic’s breast health portfolio will be available for Royal Philips to offer as part of its multi-modality deals for healthcare providers, hospitals, and more. The selected products include Hologic’s breast screening technologies, interventional radiology technologies, and its 3Dimensions Mammography System, the fastest breast tomosynthesis system in the market.
The latest earnings announcement Koninklijke Philips NV.’s (ENXTAM:PHIA) released in December 2017 showed that the company benefited from a slight tailwind, leading to a single-digit earnings growth of 3.30%. BelowRead More...
Koninklijke Philips's (PHG) new Digital Radiography-Fluoroscopy system receives approval of the U.S. Food and Drug Administration for marketing.
Koninklijke Philips NV. (ENXTAM:PHIA) is trading with a trailing P/E of 36x, which is higher than the industry average of 33.4x. Although some investors may jump to the conclusion thatRead More...
Philips (PHG) joins forces with Partners Connected Health and Triad HealthCare Network for high quality patient care with lower cost of medical non-adherence.
Philips Hue products are going outside. Available for purchase this summer in the U.S., the lighting company has a range of new outdoor lighting products extending the world of Internet of Things to the great outdoors. As Wi-Fi range and consumer demand increases, products such as these will become more available.
Quip has spent two years selling toothbrush subscriptions. Now, the start-up's focusing on attracting dental professionals.
Philips (PHG) announces that Saratoga Hospital has successfully improved patient safety and clinical outcomes with the integration of Philips' IntelliVue Guardian.
Philips (PHG) launches the HealthSuite Insights, including the Insights Marketplace that would augment the adoption of analytics as well as artificial intelligence in major healthcare sector.